Acquisition synergies Eye Care & Cure is now part of Hilco Vision through acquisitions dating back to 2018, suggesting potential cross-selling opportunities with Hilco Vision’s product lines and distribution channels to expand ophthalmic and optometric supply offerings.

Small team leverage With a lean staff (2-10 employees), there may be high value in offering scalable, self-serve procurement solutions, onboarding support, and turnkey marketing assets to accelerate sales without a large enterprise sales commitment.

Growing product line The launch of the EpiGlare line indicates a willingness to expand into diagnostics devices; opportunities exist to upsell other testing equipment, consumables, and training services to ophthalmology practices seeking bundled solutions.

Revenue uplift potential Current revenue under $1M signals a path for gradual growth via channel expansion, strategic partnerships, and targeted campaigns aimed at mid-size ophthalmology clinics and eye care networks aligned with similar market peers.

Tech-enabled operations Existing tech stack including NetSuite and WordPress offers a foundation for improving e-commerce, procurement workflows, and customer data insights to drive repeat purchases and better targeting for sales outreach.